Nbalia Soumah, DO
Obstetrics & Gynecology · Mission Hills, CANPI 1679529093
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,600 of the $3,222 with a category attached, or 80.7%. Mimedx Group, Inc. accounts for 80.7% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $1,415, 4.4 times the $321 reported in 2019.
Across 39 payments — averaging $82.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mimedx Group, Inc.$3K
- AbbVie$143
- GSK$85
- Novo Nordisk$77
- Applied Medical Resources Corporation$75
- Merck$58
- plus $183 from 8 others
What the payments were for
- Consulting fees$2,60081%
- Food & beverage$62219%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mimedx Group, Inc. | 12 | $2,600 |
| AbbVie | 3 | $143 |
| GSK | 6 | $85 |
| Novo Nordisk | 4 | $77 |
| Applied Medical Resources Corporation | 2 | $75 |
| Merck | 3 | $58 |
| Bayer | 2 | $43 |
| Aspira Women's Health Inc | 1 | $31 |
| Therapeuticsmd, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
| Organon | 1 | $19 |
| Medicem Inc. | 1 | $15 |
| Coopersurgical, Inc. | 1 | $15 |
| Hologic Sales And Service, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOVINE COLLAGEN$200
- Orilissa$123
How this compares
$3,222 in reported general payments places this provider in the 85th percentile of 3,784 obstetrics & gynecology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 62 | $1,284 |
| Estradiol (Twice Weekly)Estradiol | 20 | $937 |
| Oxybutynin Chloride ErOxybutynin Chloride | 30 | $439 |
| Fluconazole | 25 | $94 |
| Ibuprofen | 11 | $35 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Mission Hills
- Steve YuNorthridge$964K
- Samir HageRedlands$640K
- Malcolm MunroLos Angeles$609K
- Michael KrychmanCosta Mesa$547K
- Anita NelsonTorrance$530K
- Jan SegnitzSan Jose$511K
- Risa KaganBerkeley$497K
- Michael GreenOxnard$424K
- Howard SalvaySanta Cruz$421K
- Marc WinterLaguna Hills$399K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.